FundedIQ
Biotechnology

QATCH Technologies: Funding, Investors & Team (Aug 2026)

QATCH Technologies is a startup focused on life-science instrumentation. It was established with the goal of bringing to market a sensor technology that originated from Duke University. Currently, QATCH is working on a tool that can assess the injectability and manufacturability of biopharmaceutical drugs in the early stages of development. This tool is valuable due to its ability to work with very low volumes of the drug (μLs). QATCH's unique technology minimizes risks in the preclinical phase of biopharmaceutical drug development and ensures timely delivery of critical medicines to patients.

www.qatchtech.com Durham, United States 1-10 employees
Biotechnology Life Science Pharmaceutical
Total raised
$250k
Rounds
1
Latest
Undisclosed round
Jun 2023

QATCH Technologies has raised $250k across 1 funding round on record, the most recent an undisclosed round of $250k announced in Jun 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

QATCH Technologies Company Profile and Key Stats

Total funding raised
$250k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$250k in Jun 2023
Employees
1-10
reported band
Headquarters
Durham, United States

Latest funding round on record: Jun 2023.

QATCH Technologies Funding Rounds

Date
Round
Amount
Undisclosed round
$250k

QATCH Technologies Founders and Leadership Team

Name
Role
Contact
Zehra Parlak
Founder
Locked

Contact details for the QATCH Technologies team: 1 of 1 has an email address on file.

Start 14-day free trial →

QATCH Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

QATCH Technologies' latest round of $250k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like QATCH Technologies in Biotechnology and Durham

Companies Similar to QATCH Technologies

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

QATCH Technologies Funding FAQs

What does QATCH Technologies do?

QATCH Technologies is a startup focused on life-science instrumentation. It was established with the goal of bringing to market a sensor technology that originated from Duke University. Currently, QATCH is working on a tool that can assess the injectability and manufacturability of biopharmaceutical drugs in the early stages of development. This tool is valuable due to its ability to work with very low volumes of the drug (μLs). QATCH's unique technology minimizes risks in the preclinical phase of biopharmaceutical drug development and ensures timely delivery of critical medicines to patients.

How much funding has QATCH Technologies raised?

QATCH Technologies has raised $250k across 1 round on record. The most recent is an undisclosed round of $250k announced in Jun 2023.

When did QATCH Technologies last raise funding?

QATCH Technologies' most recent funding round on record is an undisclosed round of $250k, announced in Jun 2023.

Who founded QATCH Technologies?

FundedIQ lists Zehra Parlak (Founder) at QATCH Technologies.

Where is QATCH Technologies headquartered?

QATCH Technologies is based in Durham, North Carolina, United States.

How many employees does QATCH Technologies have?

QATCH Technologies is in the 1-10 employee band.

How does QATCH Technologies' funding compare to other Biotechnology startups?

QATCH Technologies' latest round of $250k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's QATCH Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for QATCH Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.